Product Program year 2023 Source: CMS Open Payments

Zolgensma

Biological Gene Therapy

Open in the dashboard

General payments

$1,548,869

3,603 payments

Research payments

$6,244,303

808 payments

Through program year 2023, $1,548,869 in general payments and $6,244,303 in research payments were reported against Zolgensma (Gene Therapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2023 General $211,615 326
2023 Research $326,818 73
2022 General $185,531 443
2022 Research $619,182 89
2021 General $145,244 289
2021 Research $623,144 114
2020 General $462,067 977
2020 Research $1,825,424 337
2019 General $544,412 1,568
2019 Research $2,849,734 195

Breakdown

Who paid General payments · program years 2019–2023
  1. AveXis $1,548,869 3,603 payments
Top recipients General payments · program year 2023
  1. Richard Finkel Neurology with Special Qualifications in Child Neurology · Memphis, TN $36,839 17% · 30 payments
  2. Perry Shieh Neurology · Los Angeles, CA $21,821 10% · 18 payments
  3. John Day Neuromuscular Medicine · Stanford, CA $20,695 10% · 20 payments
  4. Crystal Proud Neurology with Special Qualifications in Child Neurology · Norfolk, VA $17,388 8% · 19 payments
  5. Sean Tunis Baltimore, MD $15,332 7% · 12 payments

The top 5 of 91 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $107,920 55% · 39 practitioners
  2. Neurology Psychiatry & Neurology $39,038 20% · 12 practitioners
  3. Neuromuscular Medicine Psychiatry & Neurology $28,698 15% · 7 practitioners
  4. Pediatric Hematology-Oncology Pediatrics $4,754 2% · 2 practitioners
  5. Pediatric Pulmonology Pediatrics $4,726 2% · 3 practitioners

The top 5 of 20 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $53,181 25% · 10 recipients
  2. Tennessee $36,956 17% · 2 recipients
  3. Ohio $21,445 10% · 6 recipients
  4. Virginia $17,388 8% · 1 recipient
  5. New York $16,759 8% · 5 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

3,603 general · 808 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record